Mountain Lake II (MLAA) news
Recent news
Biocon's Shaw: Biosimilars a very attractive segment
Biocon, India’s largest biopharmaceutical company, has positioned itself as a key player in the global biosimilars market, with its chairman and managing director, Kiran Mazumdar-Shaw, emphasizing the segment’s growing potential. The company recently received approval for its Glargine biosimilar in…
AInvest Wire · 2d agoTerra Quantum, Axiom Intelligence Acquisition Corp 1 to merge
Terra Quantum AG, a Swiss-based quantum technology company, has signed a non-binding letter of intent (LOI) to merge with Mountain Lake Acquisition Corp. II (Nasdaq: MLAA), a special purpose acquisition company (SPAC), in a deal valued at $3.25 billion. The proposed transaction aims to accelerate…
AInvest Wire · May 26, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.